Stephen J. Shuttleworth,Cyrille D. Tomassi,Alexander R. Cecil,Somhairle Maccormick,William J. Nodes,Franck A. Silva
申请号：
US14441401
公开号：
US09676765B2
申请日:
2013.11.06
申请国别(地区):
US
年份:
2017
代理人:
摘要：
A compound of the formula: (I) or a pharmaceutically acceptable salt thereof, wherein: L is a 5-membered nitrogen-containing heteroaryl which is optionally fused to a benzene； Y is a 5, 6 or 7-membered nitrogen-containing heteroaryl, which is optionally fused to a benzene； and W is a zinc-binding group. The compounds are HDAC inhibitors and therefore have potential utility in therapy.
